Search

Taeyoon Kim

Examiner (ID: 4325, Phone: (571)272-9041 , Office: P/1651 )

Most Active Art Unit
1651
Art Unit(s)
1651, 1631, 1632
Total Applications
1176
Issued Applications
467
Pending Applications
170
Abandoned Applications
584

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11992437 [patent_doc_number] => 20170296592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES' [patent_app_type] => utility [patent_app_number] => 15/581777 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19155 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581777 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/581777
CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES Apr 27, 2017 Abandoned
Array ( [id] => 11992438 [patent_doc_number] => 20170296593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES' [patent_app_type] => utility [patent_app_number] => 15/581801 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19155 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581801 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/581801
CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES Apr 27, 2017 Abandoned
Array ( [id] => 11864795 [patent_doc_number] => 20170232080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'Treatment of Migraine Headaches with Presynaptic Neurotoxin' [patent_app_type] => utility [patent_app_number] => 15/582407 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7411 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15582407 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/582407
Treatment of migraine headaches with presynaptic neurotoxin Apr 27, 2017 Issued
Array ( [id] => 16283974 [patent_doc_number] => 20200277576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS FROM FIBROBLAST CELLS [patent_app_type] => utility [patent_app_number] => 15/779244 [patent_app_country] => US [patent_app_date] => 2017-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8769 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779244 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/779244
Method for generating induced pluripotent stem cells from fibroblast cells Apr 17, 2017 Issued
Array ( [id] => 11755347 [patent_doc_number] => 20170202214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'CRYOPRESERVATION OF CELLS AND SUBCELLULAR FRACTIONS' [patent_app_type] => utility [patent_app_number] => 15/478733 [patent_app_country] => US [patent_app_date] => 2017-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12527 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478733 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/478733
CRYOPRESERVATION OF CELLS AND SUBCELLULAR FRACTIONS Apr 3, 2017 Abandoned
Array ( [id] => 14233395 [patent_doc_number] => 20190128870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => Diagnostic Methods For Patient Specific Therapeutic Decision Making In Cancer Care [patent_app_type] => utility [patent_app_number] => 16/091434 [patent_app_country] => US [patent_app_date] => 2017-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7385 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091434 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/091434
Diagnostic Methods For Patient Specific Therapeutic Decision Making In Cancer Care Apr 3, 2017 Abandoned
Array ( [id] => 14227529 [patent_doc_number] => 20190125937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => Implantable Device for Implantation of Cells Having Anti-Inflammatory and Vascularization Capabilities and Methods of Making Thereof [patent_app_type] => utility [patent_app_number] => 16/097138 [patent_app_country] => US [patent_app_date] => 2017-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11380 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097138 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097138
Implantable Device for Implantation of Cells Having Anti-Inflammatory and Vascularization Capabilities and Methods of Making Thereof Apr 3, 2017 Abandoned
Array ( [id] => 11954776 [patent_doc_number] => 20170258927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'FORMULATIONS AND DOSES OF PEGYLATED URICASE' [patent_app_type] => utility [patent_app_number] => 15/456520 [patent_app_country] => US [patent_app_date] => 2017-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31073 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15456520 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/456520
FORMULATIONS AND DOSES OF PEGYLATED URICASE Mar 10, 2017 Abandoned
Array ( [id] => 13871357 [patent_doc_number] => 20190032019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => METHOD FOR MANUFACTURING CULTURE PRODUCT LIQUID [patent_app_type] => utility [patent_app_number] => 16/073352 [patent_app_country] => US [patent_app_date] => 2017-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 586 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073352 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/073352
METHOD FOR MANUFACTURING CULTURE PRODUCT LIQUID Mar 8, 2017 Abandoned
Array ( [id] => 11949701 [patent_doc_number] => 20170253852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-07 [patent_title] => 'Method of Fermenting Mycelium Composite Material' [patent_app_type] => utility [patent_app_number] => 15/450198 [patent_app_country] => US [patent_app_date] => 2017-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1645 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15450198 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/450198
Method of fermenting mycelium composite material Mar 5, 2017 Issued
Array ( [id] => 16785264 [patent_doc_number] => 10987669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Apparatus and method for detection of tumour cells and circulating tumour cells [patent_app_type] => utility [patent_app_number] => 16/081720 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18109 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081720 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/081720
Apparatus and method for detection of tumour cells and circulating tumour cells Mar 2, 2017 Issued
Array ( [id] => 13982417 [patent_doc_number] => 20190060366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => HIGHLY ENGRAFTABLE HEMATOPOIETIC STEM CELLS [patent_app_type] => utility [patent_app_number] => 16/080264 [patent_app_country] => US [patent_app_date] => 2017-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18817 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16080264 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/080264
HIGHLY ENGRAFTABLE HEMATOPOIETIC STEM CELLS Feb 26, 2017 Abandoned
Array ( [id] => 13827089 [patent_doc_number] => 20190017029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => Generation of Expandable Cardiovascular Progenitor Cells [patent_app_type] => utility [patent_app_number] => 16/076824 [patent_app_country] => US [patent_app_date] => 2017-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20094 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076824 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/076824
Generation of Expandable Cardiovascular Progenitor Cells Feb 23, 2017 Abandoned
Array ( [id] => 11668349 [patent_doc_number] => 20170157069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'COMPOSITION USING METFORMIN FOR PREVENTING OR TREATING IMMUNE DISEASES INCLUDING LUPUS' [patent_app_type] => utility [patent_app_number] => 15/440738 [patent_app_country] => US [patent_app_date] => 2017-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7982 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440738 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/440738
COMPOSITION USING METFORMIN FOR PREVENTING OR TREATING IMMUNE DISEASES INCLUDING LUPUS Feb 22, 2017 Abandoned
Array ( [id] => 12117289 [patent_doc_number] => 20180000875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION OF ILLNESS' [patent_app_type] => utility [patent_app_number] => 15/434376 [patent_app_country] => US [patent_app_date] => 2017-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10244 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15434376 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/434376
PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION OF ILLNESS Feb 15, 2017 Abandoned
Array ( [id] => 14454613 [patent_doc_number] => 10323259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Formulation and process for biohydrogen production [patent_app_type] => utility [patent_app_number] => 15/426815 [patent_app_country] => US [patent_app_date] => 2017-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6544 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15426815 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/426815
Formulation and process for biohydrogen production Feb 6, 2017 Issued
Array ( [id] => 14291999 [patent_doc_number] => 10286108 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Irreversible electroporation to create tissue scaffolds [patent_app_type] => utility [patent_app_number] => 15/423986 [patent_app_country] => US [patent_app_date] => 2017-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 9826 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15423986 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/423986
Irreversible electroporation to create tissue scaffolds Feb 2, 2017 Issued
Array ( [id] => 14243991 [patent_doc_number] => 10272178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-30 [patent_title] => Methods for blood-brain barrier disruption using electrical energy [patent_app_type] => utility [patent_app_number] => 15/424335 [patent_app_country] => US [patent_app_date] => 2017-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 11995 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424335 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/424335
Methods for blood-brain barrier disruption using electrical energy Feb 2, 2017 Issued
Array ( [id] => 12707668 [patent_doc_number] => 20180127722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF [patent_app_type] => utility [patent_app_number] => 15/416502 [patent_app_country] => US [patent_app_date] => 2017-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6097 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15416502 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/416502
COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF Jan 25, 2017 Abandoned
Array ( [id] => 13824135 [patent_doc_number] => 20190015552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => Vascular Extracellular Matrix Hydrogel [patent_app_type] => utility [patent_app_number] => 16/070044 [patent_app_country] => US [patent_app_date] => 2017-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17272 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070044 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/070044
Vascular extracellular matrix hydrogel Jan 12, 2017 Issued
Menu